Copper(II) and ruthenium(II)/(III) Schiff base complexes

Metal complexes of general formula [Cu(L)](ClO4)2, [Ru(L)(PPh3)2]Cl2 and [Ru(L)(PPh3)Cl]Cl2[L = 1,4-di- (o-benzylidiminophenoxy/benzylidiminophenylthio)butane] containing N2O2 or N2S2 donor atoms have been prepared and characterised by spectral, magnetic and cyclic voltammetric studies. The rhombic nature of the e.s.r. spectra of the RuIII complexes indicates an asymmetry in the electronic environment around the Ru atom. e.s.r. spectra of the CuII complexes show a typical four-line spectrum with approximate tetrahedral distortion. The observed low A values in the CuII complexes, of the order of 132–160 × 10–4cm–1, indicates a tetrahedrally distorted square planar structure.The influence of modified ligands is reflected in the metal-centered redox potentials. CuII complexes having the N2S2 chromophore, in MeCN on a glassy carbon electrode, undergo quasi-reversible reduction in the 540–680 mV range. A depression in E1/2 values for the open chain N2S2 chromophoric macrocyclic CuII complexes, compared to electronically similar cyclic tetradentate CuII analogues, is due to the increased stabilization of the CuI state by added flexibility provided through the open chain donor sites.     

Schiff base complexes of ruthenium(II) with tridentateN-methyl-S-methyldithiocarbazate ligands

Summary Schiff bases (HL) produced by the condensation ofN-methyl-S-methyldithiocarbazate with -diketones and aromatic aldehydes or ketones react with [RuHClCO(PPh₃)₃] to yield hexacoordinated complexes of the type [RuClCO(PPh₃)₂(L)]. These Schiff bases react with [RuCl₂{P(OR)₃}₄] in 11 molar ratio to yield [RuCl{P(OR)₃}₂(L)] in which L is a tridentate. The chlorine atom in the complex can be removed in coordinating solvents in the presence of anions such as [BPh₄]^– to give cationic complexes. Bis chelate complexes, [Ru{P(OR)₃}₂(L)₂] are prepared from 12 molar proportions of the reactants. These complexes were characterised by elemental analyses, i.r.,¹H n.m.r., u.v. and conductivity studies.NCL Communication No. 4224.     

Nickel(II) and copper(II) complexes of unsymmetrical tetradentate reduced Schiff base ligands

Two new reduced Schiff base ligands, [HL¹ = 4-{2-[(pyridin-2-ylmethyl)-amino]-ethylimino}-pentan-2-one and HL² = 4-[2-(1-pyridin-2-yl-ethylamino)-ethylimino]-pentan-2-one] have been prepared by reduction of the corresponding tetradentate unsymmetrical Schiff bases derived from 1:1: 1 condensation of 1,2-ethanediamine, acetylacetone and pyridine-2-carboxaldehyde/2-acetyl pyridine. Four complexes, [Ni(L¹)]ClO₄ (1), [Cu(L¹)]ClO₄ (2), [Ni(L²)]ClO₄ (3), and [Cu(L²)]ClO₄ (4) with these two reduced Schiff base ligands have been synthesized and structurally characterized by X-ray crystallography. The mono-negative ligands L¹ and L² are chelated in all four complexes through the four donor atoms to form square planar nickel(II) and copper(II) complexes. Structures of 3 and 4 reveal that enantiomeric pairs are crystallized together with opposite chirality in the nitrogen and carbon atoms. The two Cu^II complexes (2 and 4) exhibit both irreversible reductive (Cu^II/Cu^I; E_pc, −1.00 and −1.04 V) and oxidative (Cu^II/Cu^III; E_pa, +1.22 and +1.17 V, respectively) responses in cyclic voltammetry. The electrochemically generated Cu^I species for both the complexes are unstable and undergo disproportionation.     

Synthesis, spectroscopic, redox, catalytic and antimicrobial properties of some ruthenium(II) Schiff base complexes

A new series of mixed ligand semicarbazone or thiosemicarbazone complexes of Ru(II) having the general formula [RuCO(EPh₃)(B)L] (where E = P or As; B = PPh₃, AsPh₃ or Pyridine; L = dibasic tridentate ligand derived by the condensation of ethylacetoacetate/methylacetoacetate and thiosemicarbazide/semicarbazide) have been synthesized and characterized by physico-chemical, spectroscopic and electrochemical studies. A comparative study on the catalysis of oxidation of benzyl alcohol, cyclohexanol, cinnamyl alcohol, n-butanol, n-propanol and iso-butyl alcohol has been done with N-methylmorpholine-N-oxide and molecular oxygen as co-oxidants. Catalytic activity studies of the complexes in coupling reactions have been carried out. The antibacterial properties of the complexes have also been examined.     

Synthesis,characterization and catalytic studies of ruthenium(II) Schiff base complexes

Complexes of the type [Ru(CO)(EPh₃)(B)(L)] (E = P or As; B = PPh₃, AsPh₃, py or pip; L = dianion of the Schiff bases derived from the condensation of salicyloyl hydrazide with acetone, ethyl methyl ketone and salicylaldehyde have been synthesised by the reaction of equimolar amounts of [RuHCl(CO)(EPh₃)₂(B)] and Schiff bases in benzene. The resulting complexes have been characterized by analytical and spectral (i.r., electronic, n.m.r.) data. The arrangements of Ph₃P groups around the Ru metal was determined from ³¹P-n.m.r. spectra. An octahedral structure has been assigned to all the new complexes. All the complexes exhibit catalytic activity for the oxidation of benzyl alcohol and cyclohexanol in the presence of N-methylmorpholine-N-oxide as co-oxidant.     

Synthesis,characterization, electrochemical,catalytic and antimicrobial activity studies of hydrazone Schiff base ruthenium(II) complexes

Four tridentate O, N, O donor Schiff base ligands were prepared by the reaction of substituted benzhydrazide and appropriate salicylaldehyde. The complexes of these ligands were synthesized by refluxing the ligands with ruthenium(II) starting complexes of the formula [RuHCl(CO)(EPh₃)₂B] in benzene, where E = P or As; B = PPh₃ or AsPh₃ or pyridine. The newly synthesized complexes were characterized by elemental, spectral (FT‐IR, UV and NMR) and electrochemical data. On the basis of the above studies, an octahedral structure has been proposed for all the complexes. The catalytic efficiency of the complexes in aryl–aryl couplings and oxidation of alcohols was examined and their inhibition activity against the growth of the micro‐organisms was also examined. Copyright © 2009 John Wiley & Sons, Ltd.     

Catalytic amination reactions mediated by Co(II) Schiff base complexes

Co(acacen), 1, (acacen = 2,11-dihydroxy-4,9-dimethyl-5,8-diaza-2,4,8,10-dodecatetraene dianion) was found to be a highly efficient catalyst for the allylic amination of non activated alkenes, using N-(p-toluensulfonyl)iminophenyliodinane (PhINTs) as nitrene precursor. This reactivity has been extended to the less reactive C-H bond of toluene. The effect of reaction times and of added cosolvent on yields and selectivities was investigated. Under the best conditions, allylic amines were obtained in a 40-70% isolated yield. A complex derived from the stoichiometric reaction of Co(acacen), 1, with PhINTs has been isolated and spectroscopically characterized. Such a complex, although not able to transfer its NTs moiety to alkenes, is still active in catalyzing allylic amination of cyclohexene.     

Synthesis, DNA binding, antioxidant and cytotoxic activities of ruthenium(II) complexes of a Schiff base ligand

Three ruthenium(II) complexes, [Ru(CO)Cl(PPh₃)L], [Ru(CO)Cl(AsPh₃)L] and [Ru(CO)Cl(Py)L], were synthesized from the reactions of 2-(benzothiazol-2-yliminomethyl)-phenol (HL) with [RuHCl(CO)B(EPh₃)₂], where B = PPh₃, AsPh₃ or pyridine, and E = P or As. All the complexes have been characterized by physicochemical and spectroscopic methods. The structure of the free ligand HL was determined by single crystal X-ray diffraction. The binding of the free ligand and its complexes with CT-DNA was studied using electronic absorption spectroscopy. In addition, the free ligand and its complexes were subjected to antioxidant activity tests, which showed that they all possess significant scavenging effects against DPPH and OH radicals. The in vitro cytotoxicities of the compounds were assessed using tumor (HeLa and MCF-7) cell lines.     

Redox and antimicrobial studies of transition metal(II) tetradentate Schiff base complexes

Neutral tetradentate chelate complexes of Cu^II, Ni^II, Co^II, Mn^II, Zn^II and VO^II have been prepared in EtOH using Schiff bases derived from acetoacetanilido-4-aminoantipyrine and 2-aminophenol/2-aminothiophenol. Microanalytical data, magnetic susceptibility, i.r., u.v.–vis., ¹H-n.m.r. and e.s.r. spectral techniques were used to confirm the structures of the chelates. Electronic absorption and i.r. spectra of the complexes suggest a square-planar geometry around the central metal ion, except for VO^II and Mn^II complexes which have square-pyramidal and octahedral geometry respectively. The cyclic voltammetric data for the Cu^II complexes in MeCN show two waves for copper(II) copper(III) and copper(II) copper(I) couples, whereas the VO^II complexes in MeCN show two waves for vanadium(IV) vanadium(V) and vanadium(IV) vanadium(III) couples. The e.s.r. spectra of the Cu^II, VO^II and Mn^II complexes were recorded in DMSO solution and their salient features reported. The in vitro antimicrobial activity of the investigated compounds was tested against the microorganisms such as Salmonella typhi, Staphylococcus aureus, Klebsiella pneumoniae, Bacillus subtilis, Shigella flexneri, Pseudomonas aeruginosa, Aspergillus niger and Rhizoctonia bataicola. Most of the metal chelates have higher antimicrobial activity than the free ligands.     

Studies on ruthenium(II) Schiff base complexes as catalysts for transfer hydrogenation reactions

The reactions of [RuHCl(CO)(B)(EPh₃)₂] (B = EPh₃ or Py; E = P or As) and Schiff bases in 1:1 molar ratio led to the formation of [RuCl(CO)(EPh₃)(B)(L)] (E = P or As; B = PPh₃, AsPh₃ or Py; L = Schiff base ligand). The new complexes have been characterized by analytical and spectroscopic (IR, electronic and ¹H NMR) data. They have been assigned an octahedral structure. The new complexes were found to catalyse the transfer hydrogenation of ketones.     

Synthesis,characterization, antioxidant,antimicrobial and DNA binding properties of ruthenium(II), cobalt(II) and nickel(II) complexes of Schiff base containing o-vanillin

Research on Chemical Intermediates - In this study, the complex combinations of Ru(II), Co(II) and Ni(II) with Schiff base obtained through the condensation of (E)-methyl...     

Synthesis,characterization, and antimicrobial and catalytic activity of a new Schiff base and its metal(II) complexes

We presented the synthesis of a new Schiff base and its complexes properties with some transition metal ions in this study. (1-amino-2-thioxo-4-p-tolyl-1,2-dihydropyrimidin-5-yl)(p-tolyl)methanone was synthesized as the starting material, and (1-((2-hydroxynaphthalen-1-yl)methyleneamino)-2-thioxo-4-p-tolyl-1,2-dihydropyrimidin-5-yl)(p-tolyl)methanone (Hnafmmp) (1) and its Ni(II) (2), Pd(II) (3), Pt(II) (4), Cu(II) (5), Co(II) (6) complexes were prepared using above-mentioned starting material. The structures of these new compounds (ligand and its complexes) were characterized with UV–Vis, FTIR, LC–MS, ¹H NMR, ¹³C NMR, magnetic susceptibility, conductivity measurement, X-ray powder diffraction method, and thermal analyses techniques. The ¹H NMR chemical shifts of all complexes were calculated by using the gauge-invariant atomic orbital HF (3.21G) method in DMSO phases. All measured results were compared with the experimental data. The ligand and its complexes were also evaluated as antimicrobial agents against representative strains bacteria. Furthermore, we studied the catalytic activity of these compounds in Suzuki–Miyaura cross-coupling reaction in aqueous media.     

Synthesis and crystal structures of two new Schiff base cobalt(II) and nickel(II) complexes

The Schiff base ligand (HL) obtained from phenylmethanamine and 5-methoxysalicylaldehyde are used as ligands for Co(II) and Ni(II) resulting in complexes [Co(L)₂] (I) and [Ni(L)₂] (II), and their solid state structures were determined by X-ray crystallography. In both complexes, weak interactions play an important role in the molecular self-assembly. Complex I was stacked up to the 2D layers by C-H…O hydrogen bonds and C-H…π interactions. In contrast, complex II was extended into 2D sheet by C-H…O hydrogen bonds, the C-H…π interactions, and edge-to-face interactions.     

Nickel(II), copper(II), and cobalt(II) complexes derived from a new unsymmetrical ONS donor Schiff base ligand: synthesis,characterization, crystal structure,and catalytic activities

Ni(II), Cu(II), and Co(II) complexes, ML₂, with a new thioether containing ONS donors were synthesized, where L = deprotonated Schiff base. The analytical, spectral (FTIR, ¹H NMR, and UV-vis), conductivity, and magnetic studies show that the metal complexes possess octahedral geometry and are non-electrolytes. The coordination mode of ligand, 1, and nickel(II) complex, NiL₂, 2, was determined by single-crystal X-ray diffraction studies. Here, the nickel is coordinated to two oxygens, two nitrogens, and two sulfurs of two tridentate ligands with slightly distorted octahedral environment around nickel. The copper complex shows very good catalytic activities towards oxidation of organic thioethers to the corresponding sulfoxide predominantly using H₂O₂ as the oxidant.     

Tridentate Schiff base complexes of ruthenium(III) containing ONS/ONO donor atoms and their biocidal activities

New ruthenium(III) complexes of the [RuY(LL)(E)₂] type (Y = Cl or Br; LL = tridentate Schiff bases; E = PPh₃ or AsPh₃) have been synthesised by reacting [RuX₃(EPh₃)₃] (X = Cl, E = P; X = Cl or Br, E = As) or [RuBr₃(EPh₃)₂(MeOH)] with Schiff bases having the donor groups (O, N, X) viz., salicylaldehydethiosemicarbazone (X = S), salicylaldehydesemicarbazone (X = O), o-hydroxyacetophenonethiosemicarbazone (X = S) and o-hydroxyacetophenonesemicarbazone (X = O). The new complexes were characterised by elemental analysis, spectral (i.r., electronic spectra, e.p.r.), magnetic moment and cyclic voltammetry data. Biocidal activity studies were also carried out for the new complexes.     

Synthesis,crystal structures,and antibacterial activities of Schiff base nickel(II) and cadmium(II) complexes with tridentate Schiff bases

Reaction of tridentate Schiff bases with nickel and cadmium salts in methanol afforded two new mononuclear complexes, [Ni(L¹)₂] (I) and [Cd(L²)₂] (II), where L¹ and L² are the anions of 2-bromo-4-chloro-6-[(3-dimethylaminopropylimino)methyl]phenol (HL¹) and 2-bromo-4-chloro-6-[(3-morpholin-4-ylpropylimino)methyl]phenol (HL²), respectively. The complexes were characterized by singlecrystal X-ray diffraction (CIF files CCDC nos. 1428653 (I) and 1428654 for (II)), FT-IR, and elemental analysis. Complex I crystallizes in the monoclinic space group P2 ₁/c, with a = 8.8216(8), b = 14.0424(8), c = 11.8687(12) Å, β = 111.238(2)°, V = 1370.4(2) ų, Z = 2. Complex II crystallizes in the monoclinic space group P2 ₁/n, with a = 9.6774(4), b = 15.8970(6), c = 20.3144(7) Å, β = 90.408(2)°, V = 3125.1(2) ų, Z = 4. The metal atoms in the complexes are coordinated by two tridentate Schiff base ligands, forming octahedral coordination. The free Schiff bases and the complexes were assayed for antibacterial activities. Both complexes are more active against the bacteria than the free Schiff bases. Complex II has the MIC value of 0.39 μg mL^–1 against Bacillus subtilis.     

Novel bidentate ruthenium(III) Schiff base complexes: synthetic,spectral, electrochemical,catalytic and antimicrobial studies

Ru^III complexes of the type [RuX(L)₂(E)] (X = Cl or Br; L = novel bidentate Schiff base ligand; E = PPh₃ or AsPh₃) have been prepared by reacting [RuX₃(E)₃] or [RuBr₃(PPh₃)₂(MeOH)] with two novel bidentate Schiff base ligands derived from 4-(1-methyl-1-mesitylcyclobutane-3-yl)-2-aminothiazole, in a 1:2 molar ratio in benzene, and characterised by analytical, spectral (i.r., electronic, ¹H-, ¹³C- n.m.r., and e.p.r.) and electrochemical data. An octahedral structure has been tentatively proposed for all the new complexes. The thermal properties of the ligands and their complexes have been studied by t.g.a. The new Ru^III complexes are effective catalysts for the oxidation of alcohols to carbonyl compounds but are unable to oxidise alkenes in the presence of N-methylmorpholine-N-oxide (NMO) as co-oxidant. The antimicrobial activity of the ligands and complexes have also been tested against six microorganisms.     

Electrochemical, catalytic and antimicrobial activities of N-functionalized cyclam based unsymmetrical dicompartmental binuclear nickel(II) complexes

Five binuclear nickel(II) complexes have been prepared by simple Schiff base condensation of the compound 1,8-[bis(3-formyl-2-hydroxy-5-bromo)benzyl]-l,4,8,11-tetraazacyclotetradecane (L) with appropriate aliphatic or aromatic diamine, nickel(II) perchlorate and triethylamine. All the complexes were characterized by elemental and spectral analysis. Positive ion FAB mass spectra show the presence of dinickel core in the complexes. The electronic spectra of the complexes show red shift in the d–d transition. Electrochemical studies of the complexes show two irreversible one electron reduction processes in the range of 0 to −1.4 V. The reduction potential of the complexes shifts towards anodically upon increasing chain length of the macrocyclic ring. All the nickel(II) complexes show two irreversible one electron oxidation waves in the range 0.4–1.6 V. The observed rate constant values for catalysis of the hydrolysis of 4-nitrophenyl phosphate are in the range of 1.36 × 10⁻²–9.14 × 10⁻² min⁻¹. The rate constant values for the complexes containing aliphatic diimines are found to be higher than the complexes containing aromatic diimines. Spectral, electrochemical and catalytic studies of the complexes were compared on the basis of increasing chain length of the imine compartment. All the complexes show higher antimicrobial activity than the ligand and metal salt.     

Recent advances in anticancer ruthenium Schiff base complexes

Nowadays in cancer treatment, both metal complexes and organic molecules are being widely used. Current years have seen a surge of interest in the application of organometallic compounds to treat cancer and other diseases. Undeniably, the unique properties of organometallic compounds, intermediate between those of classical inorganic and organic materials, provide new opportunities in the field of medicinal chemistry. Since the discovery of cisplatin, many transition metal complexes have been synthesized and assayed for anticancer activity. In recent years, ruthenium-based Schiff base complexes have emerged as promising antitumor and antimetastatic agents with potential uses in treatment of platinum-resistant tumors or as alternatives to platinum-based chemotherapy. Advantages of utilizing ruthenium complexes in drug development include reliable methods of synthesizing stable complexes; the ability to tune ligand affinities, electron transfer and substitution rates, and reduction potentials; and an increasing knowledge of the biological effects of such complexes. This great expansion of ruthenium-based Schiff base complexes is mainly due to the unique ability of the ruthenium core to permit multiple oxidation states, hence versatile electron-transfer pathways, and because of the ease of preparation with versatile and variable-denticity Schiff base ligands. This review aims to bring the reader up to date with the more recent Ru(II)/(III)-based Schiff base complexes that have been synthesized and investigated for their cytotoxicity.